Nancy Krieger MD, is the Chief Medical Officer of Talaris Therapeutics. Dr. Krieger has 15 years of diverse global experience in the pharmaceutical industry, in cellular therapy, solid organ and stem cell transplantation, immunology/inflammation, bone metabolism, rare diseases, as well as liver and chronic kidney disease. Prior to joining Talaris, she advanced through roles of increasing responsibility at Novartis from 2007 to 2018, most recently as a senior global program clinical head in hepatology. Dr. Krieger served as a medical director at Bristol-Myers Squibb from 2004 to 2007, playing a significant role in the clinical development of the Belatacept Transplant Program. Before joining industry, Dr. Krieger was a staff transplant surgeon at Mount Sinai School of Medicine in New York, where she had an active practice in liver transplantation as well as a basic science laboratory investigating lymphocyte trafficking in transplant tolerance. She completed her transplant fellowship at the University of Wisconsin, and general surgical residency at Stanford University, including a 3-year postdoctoral fellowship in Stanford’s immunology department. Nancy earned her M.D. at Columbia University College of Physicians and Surgeons.